Interference of CD38 monoclonal antibody in blood compatibility testing and its countermeasures: A general consensus among experts

Jianqing MI; Xiaohong CAI; Shaoyuan WANG; Lihua HU; Ting NIU; Deqing WANG; Chengcheng FU; Chunyan SUN; Dong XIANG; Wen GAO; Tianhong MIAO; Liye ZHONG; Baohua QIAN; Gang AN; Rong XIA; Rong GUI; Jing LIU; Xiaofeng TANG; Jue XIE; Jia GAN; Jiang WU; Danhui FU; Li QIN; Jian HOU; Xuefeng WANG.
Chinese Journal of Blood Transfusion ; (12): 327-334, 2021.
Artículo en Zh | WPRIM | ID: wpr-1004515

Documentos relacionados

  1. 2-Mercaptoethanol (2-ME)-based IATs or Polybrene method mitigates the interference of daratumumab on blood compatibility tests.
  2. Use of thiol reagents to disperse cold autoagglutination.
  3. Synthesis and Photochemical Properties of Fluorescent Metabolites Generated from Fluorinated Benzoylmenadiones in Living Cells.
  4. Sulfhydryl treatment of serum or plasma for the reduction of IgM antibodies.
  5. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  6. Formation of protein adducts with Hydroperoxy-PE electrophilic cleavage products during ferroptosis.
  7. A Nucleophilic Deprotection of Carbamate Mediated by 2-Mercaptoethanol.
  8. Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role.
  9. Preparation of 2-Methoxyestradiol Self-emulsified Drug Delivery System and the Effect on Combination Therapy with Doxorubicin Against MCF-7/ADM Cells.
  10. The Rheology and Printability of Cartilage Matrix-Only Biomaterials.